An Fgr kinase inhibitor attenuates sepsis-associated encephalopathy by ameliorating mitochondrial dysfunction, oxidative stress, and neuroinflammation via the SIRT1/PGC-1α signaling pathway

Yuqiang Liu,Han Yang,Nanbo Luo,Yifei Fu,Fang Qiu,Zhenglong Pan,Xiongjuan Li,Wenling Jian,Xinping Yang,Qingsheng Xue,Yan Luo,Buwei Yu,Zhiheng Liu
DOI: https://doi.org/10.1186/s12967-023-04345-7
IF: 8.44
2023-07-21
Journal of Translational Medicine
Abstract:Sepsis-associated encephalopathy (SAE) is characterized by diffuse brain dysfunction, long-term cognitive impairment, and increased morbidity and mortality. The current treatment for SAE is mainly symptomatic; the lack of specific treatment options and a poor understanding of the underlying mechanism of disease are responsible for poor patient outcomes. Fgr is a member of the Src family of tyrosine kinases and is involved in the innate immune response, hematologic cancer, diet-induced obesity, and hemorrhage-induced thalamic pain. This study investigated the protection provided by an Fgr kinase inhibitor in SAE and the underlying mechanism(s) of action.
medicine, research & experimental
What problem does this paper attempt to address?